Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,157
Closed -$120K 1128
2022
Q1
$120K Buy
+15,157
New +$131K ﹤0.01% 1541
2020
Q4
Sell
-16,111
Closed -$187K 1647
2020
Q3
$187K Buy
+16,111
New +$187K ﹤0.01% 1782
2018
Q1
Sell
-7,600
Closed -$215K 1934
2017
Q4
$215K Buy
+7,600
New +$179K ﹤0.01% 1701

Other funds holding AXGN

Paloma Partners's AXGN Position: Q2 2022 in Review

Paloma Partners sold out of Axogen (AXGN) in Q2 2022, closing a stake of 15,157 shares — an estimated $120K sold.

Paloma Partners first reported a position in AXGN in Q4 2017 and held it in 3 quarters. The position peaked at $215K in Q4 2017. 113 funds tracked by Wall St. Rank hold AXGN as of Q2 2022.

  • Paloma Partners reported no remaining Axogen position as of Q2 2022 after selling out during the quarter.
  • Paloma Partners sold 15,157 Axogen shares in Q2 2022, an estimated $120K.
  • Paloma Partners first reported a position in Axogen in Q4 2017 and held it in 3 quarters.
  • Paloma Partners's Axogen position peaked at $215K in Q4 2017.
  • 113 funds tracked by Wall St. Rank held Axogen as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.